Cefotaxime kinetics in plasma and synovial fluid following intravenous administration in horses

Journal of Veterinary Pharmacology and Therapeutics

Volumn 27, Issue 5, 2004, Pages 293-298

  Orsini, James A ^a   Moate, P J ^a   Engiles, J ^a   Norman, T ^b   Poppenga, R ^a   Benson, C E ^a   Boston, R C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BACTERIAL ARTHRITIS; BACTERIUM ISOLATE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG SYNOVIAL FLUID LEVEL; ESCHERICHIA COLI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; ARTHRITIS, INFECTIOUS; CEFOTAXIME; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG ADMINISTRATION SCHEDULE; ESCHERICHIA COLI; HORSE DISEASES; HORSES; INFUSIONS, INTRAVENOUS; JOINT DISEASES; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SYNOVIAL FLUID;

ANIMALIA; BACTERIA (MICROORGANISMS); EQUIDAE; EQUUS CABALLUS; ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 8344279543     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2004.00596.x     Document Type: Article

References (22)

1. Boccazzi, A., Tonelli, P., Bellosta, C. et al. (1998) Clinical and pharmacological evaluation of a modified cefotaxime bid regimen versus traditional tid in pediatric lower respiratory tract infections. Diagnostic Microbiology and Infectious Disease, 32, 265-272.
2. Braga, P.C., Sasso, M.D. & Sala, M.T. (2000) Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence. The Journal of Antimicrobial Chemotherapy, 45, 15-25.
3. Cervantes, C.C., Brown, M.P., Gronwall, R. et al. (1993) Pharmacokinetics and concentrations of ceftiofur sodium in body fluids and endometrium after repeated intramuscular injections in mares. American Journal of Veterinary Research, 54, 573-575.
4. Duflee, N.E., Stang, B.E. & Schaefler, D.J. (1997) The pharmacokinetics of cefadroxil over a range of oral doses and animal ages in the foal. Journal of Veterinary Pharmacology and Therapeutics, 20, 427-433.
5. Gardner, S.Y. & Aucoin, D.P. (1994) Pharmacokinetics of ceftriaxone in mares. Journal of Veterinary Pharmacology and Therapeutics, 17, 155-156.
6. Gardner, S.Y., Sweeney, R.W. & Divers, T.J. (1993) Pharmacokinetics of cefotaxime in neonatal pony foals. American Journal of Veterinary Research, 54, 576-579.
7. Kraemer, H.J., Gehrke, R., Breithaupt, A. et al (1997) Simultaneous quantification of cefotaxime, desacetylacefotaxime, ofloxacine and ciprofloxacine in ocular aqueous humor and in plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Application, 700, 147-153.
8. Linke, E.G., Henry, J.B. & Statland, B.E. (1979) Clinical Diagnosis and Management by Laboratory Methods, 16th edn. pp. 53-76, W. B. Saunders Co., Philadelphia. PA. USA.
9. Mandell, G.L. & Sande, M.A. (1991) Antimicrobial agents. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th edn. Eds Goodman Gilman, A., Rall, T.W., Nies. A.S. & Taylor, P. pp. 1085-1092. Pergamon Press. New York, USA.
10. Meyer, J.C., Brown, M.P., Gronwall, R.R. et al. (1992) Pharmacokinetics of ceftiofur sodium in neonatal foals after intramuscular injection. Equine Veterinary Journal, 24, 485-486.
11. Mills, M.L., Rush, B.R., St Jean, G. et al. (2000) Determination of synovial fluid and serum concentrations, and morphologic effects of intra-articular ceftiofur sodium in horses. Veterinary Surgery, 29, 398-406.
12. Morris, D.D., Rutkowski, J. & Lloyd, K.C.K. (1987) Therapy in two cases of neonatal foal septicaemia and meningitis with cefotaxime sodium. Equine Veterinary Journal, 19, 151-154.
13. Murray. P.R., Baron, E.J., Pfaller, M.A. et al. (2001) Manual of Clinical Microbiology. Vol. 9, pp. 1535-1536. ASM Press, Washington, DC, USA.
14. Nathwani, D. (2000) Place of parenteral cephalosporins in the ambulatory setting: clinical evidence. Drugs, 59, 37-46.
15. National Committee for Clinical Laboratory Standards (NCCLS) (2002) Performance Standards for Antimicrobial Susceptibility Testing. M100 Series; Latest Annual Edition.
16. Ringger, N.C., Pearson, E.G., Gronwall, R. et al. (1996) Pharmacokinetics of ceftriaxone in healthy horses. Equine Veterinary Journal, 28, 476-479.
17. Rorvik, A.M. (1995) Methods and errors in measurements of synovial fluid volume in stifles with low volume and high viscosity synovial fluid. An experimental study in goats. Acta Veterinaria Scandinavica, 36, 213-222.
18. Soma, L.R., Uboh, C.E., Rudy, J.A. & Perkowski, S.Z. (1995) Plasma and synovial fluid kinetics, disposition and urinary excretion of naproxen in the horse. American Journal of Veterinary Research, 56, 1075-1080.
19. Soraci, A.L., Mestorino, O.N. & Errecalde, J.O. (1996) Pharmacokinetics of cefoperazone in horses. Journal of Veterinary Pharmacology and Therapeutics, 19, 39-43.
20. Stefanovski, D., Moate, P.J. & Boston, R.C. (2003) WinSAAM: a windows based compartmental modeling system. Metabolism: Clinical and Experimental, 52, 1153-1166.
21. Wastney, M.E., Patterson, B.H., Linares, O.A. et al (1999) Investigating Biological Systems using Modeling - Strategies and Software. Academic Press, San Diego, USA.
22. Wilson, W.R., Bouza, E., Lode, H. et al. (1997) The use of cefotaxime for the treatment of common infections: in vitro, pharmacokinetic and clinical considerations. Journal of Chemotheraphy, 9, 5-18.